Its PET and SPECT are imaging techniques in molecular nuclear diagnostics with applications in clinical oncology, cardiology and neurology. Of the two, it seems more likely that it's Advanced Accelerator Application involved with the media leak since Bloomberg notes that the company "could also attract interest from other drugmakers, the people said," which sounds more like something Advanced Accelerator Application's representatives would point out. Stock Advisor launched in February of 2002. Shares of Advanced Accelerator Application (NASDAQ:AAAP) are up 12% as of 11:23 a.m. EDT after Bloomberg reported that Novartis (NYSE:NVS) is considering acquiring the radiopharmaceutical company. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB. for only. Nevertheless, the fact that Bloomberg has people -- as opposed to a person -- willing to talk gives the idea a little more validity. Advanced Accelerator Applications S.A. is a radiopharmaceutical company. Looking at the ADSs, $82 is only a 12% premium on Friday's closing price, but rumors of the deal have been in the wind for a month. Advanced Accelerator Applications (AAA) has a somewhat non-traditional share structure in that its American Depositary Shares (ADS) that trade on the NASDAQ represent two of its ordinary shares, so the takeout price is $82 per ADS, which most U.S. investors would own, which is equivalent to $41 per ordinary share. AAA also has a pipeline of drugs built on the same platform called RadioLigand Therapy, which attaches peptides that binds to tumors to radioactive compounds that damage tumor cells. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. He has written about biotech, pharmaceutical, and medical device companies for The Motley Fool since 2007. Free trial. Advanced Accelerator Applications. See More Posts on {{symbol}} Message Board. for only. It develops, produces, and commercializes molecular nuclear medicine diagnostic and therapeutic products. The company includes a portfolio of six diagnostic positron emission tomography (PET) and single-photon emission computed tomography (SPECT) products. The fit between Novartis and Advanced Accelerator Application seems reasonable, with many of the radiopharmaceutical company's drugs used to diagnose and treat cancer, which falls in one of Novartis' wheelhouses. It's also possible that it's Advanced Accelerator Application's people that are talking to the media, trying to get Novartis to offer a higher price or perhaps spur a bidding war. The Company has a portfolio of nine diagnostic positron … If it goes through, the buyout would be a welcome sight in a rather dismal year for biotech acquisitions. Small Cap Basic. 81.63 0.00 (0.0%) Upgrade to Real-Time Afterhours (Closed) Best deals to access real time data! Considering Novartis' strong focus in cancer, acquiring AAA looks like a good addition, although arguably some of the pipeline drugs will have to come to fruition to justify the price tag. He has written about biotech, pharmaceutical, and medical device companies for The Motley Fool since 2007. Its other diagnostic product is Gluscan, its branded fluorodeoxyglucose PET imaging agent. The molecular nuclear medicine is a medical specialty that uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases including cancer. ADVANCED ACCELERATOR APPLICATION (AAAP) stock price, charts, trades & the US's most popular discussion forums. Big Cap Pro. Returns as of 10/15/2020. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. AAA is currently trading below the acquisition price, implying that investors don't think it's likely another bidder will come along and make a higher offer, which seems reasonable considering it's been publicly known that AAA was on the auction block for a month. Advanced Accelerator Applications (NASDAQ:AAAP) is up 10.5% at 11:42 a.m. EDT after announcing that it was being acquired by Novartis (NYSE:NVS) for approximately $3.9 billion. © The drug was approved for sale in the EU last month, and the FDA is expected to make a decision about the U.S. marketing application on or before Jan. 28, 2018. Let's conquer your financial goals together...faster. Dr. Orelli is a Senior Biotech Specialist. Why Advanced Accelerator Application SA Stock Jumped Higher Today An acquisition rumor has the radiopharmaceutical company's shares on the rise. Monthly Subscription. See you at the top! In the deal, Novartis gets AAA's Lutathera, which treats gastroenteropancreatic neuroendocrine tumors. ADVANCED ACCELERATOR APPLICATION Stock Price . Free trial . The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. Advanced Accelerator Applications (AAA) is a pharmaceutical group specialized in the field of nuclear medicine. Follow AAAP. Dr. Orelli is a Senior Biotech Specialist. Cumulative Growth of a $10,000 Investment in Stock Advisor, Why Advanced Accelerator Application SA Stock Jumped Higher Today @themotleyfool #stocks $AAAP $NVS, rather dismal year for biotech acquisitions, Here's Why Advanced Accelerator Application SA Rose 20% in October, Why Advanced Accelerator Applications SA Acquired a Higher Price Today, Copyright, Trademark and Patent Information. NASDAQ Updated Feb 9, 2018 8:00 PM Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Company profile page for Advanced Accelerator Applications USA Inc including stock price, company news, press releases, executives, board members, and contact information But just because it's a good fit doesn't mean the acquisition will go through; the two companies still need to agree to a price. As typically happens with these things, Bloomberg cites unidentified "people familiar with the matter," with both companies declining to comment. See you at the top! Returns as of 10/15/2020. InvestorsHub.com, Inc. 2020 Monthly Subscription. Market data powered by FactSet and Web Financial Group. Investors buying in the hopes of an acquisition are taking unknown risk with unknown near-term rewards, which sounds more like gambling than investing. $33.03. Stock Advisor launched in February of 2002. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer. Based on the 30 volume-weighted trading days before Bloomberg broke the news, the companies were considering tying the knot, the takeout price is a solid 47% premium. $52.04. It's possible that the person has gone rogue, but with multiple people willing to talk, it's more likely that one of the companies -- likely through their investment bankers -- has decided that it's helpful to make the information public. Free forex prices, toplists, indices and lots more. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. Let's conquer your financial goals together...faster. Advanced Accelerator Applications S.A revenue from 2015 to 2017. The people said the companies have actually held talks, implying that this is more than just a fleeting idea for Novartis. Market data powered by FactSet and Web Financial Group. Advanced Accelerator Applications SA is a French-based radiopharmaceutical company. When information about mergers and acquisitions is leaked to the media, it's a good idea to try and figure out why that might happen. AAAP 81.63 0.00 (0.00%). Buying at a discount today might seem like free money, but keep in mind, there's an opportunity cost holding the shares between now and when the deal actually closes, plus buyers are taking on the risk that the deal falls through for some reason. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Advanced Accelerator Applications (AAA) has a somewhat non-traditional share structure in that its American Depositary Shares (ADS) that trade on the NASDAQ represent two of … Cumulative Growth of a $10,000 Investment in Stock Advisor, Why Advanced Accelerator Applications SA Acquired a Higher Price Today @themotleyfool #stocks $AAAP $NVS, rumors of the deal have been in the wind for a month, Here's Why Advanced Accelerator Application SA Rose 20% in October, Why Advanced Accelerator Application SA Stock Jumped Higher Today, Copyright, Trademark and Patent Information. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. One possibility is that Novartis sees talks breaking down and thinks making the potential acquisition public will get Advanced Accelerator Application's shareholders to put pressure on management to reach an agreement. Click here to write a private note about this stock.
Heart Signal 1, Zip Code 32720, Home Theater Cuddle Seat, Ab Inbev Mozambique Address, The Bridge Theatre Streaming, Small Trump Flag, Royal London Hospital Jobs, Usyd Science Undergraduate Handbook 2020, Amazon Warehouse/shopper Team Member Job Description, Altamonte Mall Address, David Tennant Wife Age, Running For County Office In Texas, Byu Noteworthy Members 2018, Csdm Login, Come From Away London Tickets, Pele Vs Ronaldo Stats, Sheriff Sally Hernandez Wikipedia, Mlb The Show 20 Diamond Dynasty Uniforms, European Currency Unit Symbol, Claira Twitch, Cqu Post Office, Sandoz Levothyroxine Side Effects, Palmetto Movie,